Inayat Bashir Pathan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Inayat Bashir Pathan has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Santosh Shelke
Department of Pharmaceutics, Srinath College of Pharmacy, Aurangabad, India
3 shared publications Wahid Ambekar
Department of Pharmaceutics, Dr. VVPF’s College of Pharmacy, Ahmednagar, India
3 shared publicationsNahid Anjum Hafizuddin Chishti
Department of Pharmaceutics, Y. B. Chavan College of Pharmacy, Dr. Rafiq Zakaria Campus, Chhatrapati Sambhajinagar, Dist- Chhatrapati Sambhajinagar, India
2 shared publicationsShripad Bairagi
MES College of Pharmacy, Sonai
2 shared publicationsShripad M. Bairagi
Department of Pharmacology, MES College of Pharmacy, Sonai, Ahmednagar, India
2 shared publications- Wahid Ambekar
Department of Pharmaceutics, Dr. VVPF’s College of Pharmacy, Ahmednagar, Maharashtra, India
2 shared publications
Latest Publications
- 5 March 2024
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 19 (2) , 1-17
Design and Development of Immediate Release Pellets Formulation Containing Co Amorphous Mixture of Aceclofenac: In-Vitro and In-Vivo Study
- 5 March 2024
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 19 (2) , 1-17
Design and Development of Immediate Release Pellets Formulation Containing Co Amorphous Mixture of Aceclofenac: In-Vitro and In-Vivo Study
- Open Access
- 1 January 2024
- Published by Marmara University in Journal of Research in Pharmacy
- Vol. 28(5) (28(5)) , 1536-1549
Formulation, optimization and evaluation of pellets loaded glipizide co amorphous mixture using central composite design to enhance solubility
The objective of this study was to prepare a co-amorphous blend of BCS class II drug, glipizide (GPZ), using arginine (ARG) as co former. The co-amorphous GPZ-ARG mixtures (molar ratios 1:1, 1:2 and 2:1) were prepared by mechanical activation (ball milling) with different milling times. The obtained mixtures were characterized with respect to their thermal properties, possible molecular interactions, dissolution properties and physical stability and compared to the behaviour of pure crystalline form. Solid-state characterization of mixture revealed amorphization of GPZ after 90 min. of ball milling. GPZ-ARG co amorphous mixture (1:2) upon ball milling for 90 min. exhibited maximum solubility (3876.8 µg/ml) compared to pure drug (300.89 µg/ml). The resulting best co amorphous blend was incorporated into pellets which were prepared by extrusion spheronisation technique. The parameters related to process of pelletisation and product related parameters were optimized by using 4-factor, 5-level Central Composite Design. The pellets containing co amorphous blend, prepared by using optimal parameter settings, showed 95.67% Drug Release in 120 min. (F23). The co-amorphous mixture and the optimized formulation were found to be stable when subjected to stability study as per ICH guideline. It was concluded that co amorphous is a promising approach to overcome the solubility constraint of Glipizide which would be helpful in better management of the disease.
- 1 January 2024
- Published by Marmara University in Journal of Research in Pharmacy
- Vol. 28(5) (28(5)) , 1536-1549
Open AccessFormulation, optimization and evaluation of pellets loaded glipizide co amorphous mixture using central composite design to enhance solubility
The objective of this study was to prepare a co-amorphous blend of BCS class II drug, glipizide (GPZ), using arginine (ARG) as co former. The co-amorphous GPZ-ARG mixtures (molar ratios 1:1, 1:2 and 2:1) were prepared by mechanical activation (ball milling) with different milling times. The obtained mixtures were characterized with respect to their thermal properties, possible molecular interactions, dissolution properties and physical stability and compared to the behaviour of pure crystalline form. Solid-state characterization of mixture revealed amorphization of GPZ after 90 min. of ball milling. GPZ-ARG co amorphous mixture (1:2) upon ball milling for 90 min. exhibited maximum solubility (3876.8 µg/ml) compared to pure drug (300.89 µg/ml). The resulting best co amorphous blend was incorporated into pellets which were prepared by extrusion spheronisation technique. The parameters related to process of pelletisation and product related parameters were optimized by using 4-factor, 5-level Central Composite Design. The pellets containing co amorphous blend, prepared by using optimal parameter settings, showed 95.67% Drug Release in 120 min. (F23). The co-amorphous mixture and the optimized formulation were found to be stable when subjected to stability study as per ICH guideline. It was concluded that co amorphous is a promising approach to overcome the solubility constraint of Glipizide which would be helpful in better management of the disease.
- 30 November 2020
- Published by Bentham Science Publishers Ltd. in Nanoscience & Nanotechnology-Asia
- Vol. 10 (6) , 766-777
Dermal Delivery of Meloxicam Nanosuspensions based Gel: Optimization with Box Behnken Design Experiment Approach: Ex Vivo and In Vivo Study
Background: Transdermal delivery of meloxicam is advantageous than the oral route in the treatment of pain management. Objective: The goal of the present study is to formulate and evaluate meloxicam (MX) loaded nanosuspensions based gel for transdermal application. Methods: The formulation parameters were optimized using Box Behnken design (BBD) taking three independent variables and three responses. Formulations were evaluated for particle size (nm), polydispersity index (PDI), zeta potential (mV), ex vivo permeation, in vivo study, morphology, FTIR, skin irritation and, stability study. Optimized formulation having Poloxamer 188 (0.4 mg), PVP K30 (0.5 mg) and sonication time (60 min.) demonstrated smaller particle size (159.2 ± 3.5 nm), low PDI (0.120 ± 0.01) and higher zeta potential value (-29 ± 4mV). Results: In the ex vivo study, MX-NG showed a significant increase (p<0.05) in the flux (24.40 ± 2.6 μg/cm2/h) of meloxicam through the human cadaver skin as compared to other formulations. In the in- vivo study, MX-NG showed a significant (p<0.05) increase in anti-inflammatory activity as compared to marketed gel. Conclusion: Thus, it is concluded that the developed meloxicam loaded nanosuspensions based gel showed maximum therapeutic effects in rats.
- 30 November 2020
- Published by Bentham Science Publishers Ltd. in Nanoscience & Nanotechnology-Asia
- Vol. 10 (6) , 766-777
Dermal Delivery of Meloxicam Nanosuspensions based Gel: Optimization with Box Behnken Design Experiment Approach: Ex Vivo and In Vivo Study
Background: Transdermal delivery of meloxicam is advantageous than the oral route in the treatment of pain management. Objective: The goal of the present study is to formulate and evaluate meloxicam (MX) loaded nanosuspensions based gel for transdermal application. Methods: The formulation parameters were optimized using Box Behnken design (BBD) taking three independent variables and three responses. Formulations were evaluated for particle size (nm), polydispersity index (PDI), zeta potential (mV), ex vivo permeation, in vivo study, morphology, FTIR, skin irritation and, stability study. Optimized formulation having Poloxamer 188 (0.4 mg), PVP K30 (0.5 mg) and sonication time (60 min.) demonstrated smaller particle size (159.2 ± 3.5 nm), low PDI (0.120 ± 0.01) and higher zeta potential value (-29 ± 4mV). Results: In the ex vivo study, MX-NG showed a significant increase (p<0.05) in the flux (24.40 ± 2.6 μg/cm2/h) of meloxicam through the human cadaver skin as compared to other formulations. In the in- vivo study, MX-NG showed a significant (p<0.05) increase in anti-inflammatory activity as compared to marketed gel. Conclusion: Thus, it is concluded that the developed meloxicam loaded nanosuspensions based gel showed maximum therapeutic effects in rats.
- 24 November 2020
- Published by Taylor & Francis in Particulate Science and Technology
- Vol. 39 (7) , 859-867
Design and optimization of pellets formulation containing curcumin ascorbic acid co-amorphous mixture for ulcerative colitis management
Curcumin is known for its various therapeutic properties like anti-inflammatory, antioxidant, anticancer, however, its oral use is restricted due to its low solubility and dissolution rate in alkaline pH. In this study co-amorphous mixture of curcumin–ascorbic acid (CU:AA) of different molar ratios was prepared using the ball milling method. The solubility and characterization of the mixture were studied using FTIR, DSC, and XRD study. Mixture (1:0.50) molar ratio showed the highest solubility and was formulated in pellets dosage and optimized using 32 full factorial designs. The solubility results revealed that a significant increase (p < 0.005) in the solubility of curcumin by the ratio 1:0.50 (212 ± 12 µg/ml) compared to the pure drug (90.0 ± 10 µg/ml). XRD and DSC studies confirmed the formation of amorphous curcumin, whereas FTIR elucidated weak hydrogen interactions. In-vitro dissolution study results showed the (CU:AA) ratio (1:0.50) higher percent drug release (81.61 ± 5.12%) compared to the pure drug (19.44 ± 4.60%). The developed formulations are found to be stable. Therefore, the prepared pellets of co-amorphous mixture enhance the solubility, dissolution rate, and stability of curcumin in higher pH, which will become a promising approach for combination therapy in the treatment of ulcerative colitis patients.
- 24 November 2020
- Published by Taylor & Francis in Particulate Science and Technology
- Vol. 39 (7) , 859-867
Design and optimization of pellets formulation containing curcumin ascorbic acid co-amorphous mixture for ulcerative colitis management
Curcumin is known for its various therapeutic properties like anti-inflammatory, antioxidant, anticancer, however, its oral use is restricted due to its low solubility and dissolution rate in alkaline pH. In this study co-amorphous mixture of curcumin–ascorbic acid (CU:AA) of different molar ratios was prepared using the ball milling method. The solubility and characterization of the mixture were studied using FTIR, DSC, and XRD study. Mixture (1:0.50) molar ratio showed the highest solubility and was formulated in pellets dosage and optimized using 32 full factorial designs. The solubility results revealed that a significant increase (p < 0.005) in the solubility of curcumin by the ratio 1:0.50 (212 ± 12 µg/ml) compared to the pure drug (90.0 ± 10 µg/ml). XRD and DSC studies confirmed the formation of amorphous curcumin, whereas FTIR elucidated weak hydrogen interactions. In-vitro dissolution study results showed the (CU:AA) ratio (1:0.50) higher percent drug release (81.61 ± 5.12%) compared to the pure drug (19.44 ± 4.60%). The developed formulations are found to be stable. Therefore, the prepared pellets of co-amorphous mixture enhance the solubility, dissolution rate, and stability of curcumin in higher pH, which will become a promising approach for combination therapy in the treatment of ulcerative colitis patients.
- 23 June 2020
- Published by Springer Nature in BioNanoScience
- Vol. 10 (3) , 633-648
Poloxamer-Based In Situ Nasal Gel of Naratriptan Hydrochloride Deformable Vesicles for Brain Targeting
- 23 June 2020
- Published by Springer Nature in BioNanoScience
- Vol. 10 (3) , 633-648
Poloxamer-Based In Situ Nasal Gel of Naratriptan Hydrochloride Deformable Vesicles for Brain Targeting
- Open Access
- 6 June 2019
- Published by Editorial de la Universidad de Granada in Ars Pharmaceutica (Internet)
- Vol. 60 (2) , 101-108-108
Formulación y evaluación de ketoprofeno cargado de nanogel de quitosán para el manejo del dolor: estudio ex vivo e in vivo
Objetivo: El objetivo de este estudio fue desarrollar y evaluar un gel a base de nanoemulsión (nanogel) para el suministro transdérmico de ketoprofeno. Entre los diversos excipientes probados, se seleccionaron el ácido oleico, la mezcla de 80 y el etanol como aceite, surfactante y co-surfactante. Métodos: La región de las nanoemulsiones se identificó mediante la construcción de diagramas de fase pseudoternarios utilizando la titulación de la fase acuosa. La nanoemulsión preparada se sometió a diferentes estudios de estabilidad termodinámica y la nanoemulsión que pasó las pruebas de estabilidad termodinámica se evaluó para determinar la viscosidad, el índice de refracción, el tamaño de las gotitas, la microscopía electrónica de transmisión y el estudio de permeación ex-vivo utilizando piel de cadáver humano Resultados: Sobre la base de la evaluación, la formulación de C1, que consiste en 3.09% peso / peso de la fase oleosa, 60.54% peso / peso de Smix y 36.36% peso / peso de agua destilada se seleccionaron como una formulación optimizada y se convirtieron a nanogel utilizando quitosano como Un agente gelificante. Nanogel se evaluó para estudio ex-vivo e in vivo. El nanogel mostró un aumento significativo en la actividad antiinflamatoria en comparación con el gel convencional. Conclusión: En conclusión, el nanogel podría ser un sistema prometedor para mejorar la administración transdérmica del ketoprofeno.
- 6 June 2019
- Published by Editorial de la Universidad de Granada in Ars Pharmaceutica (Internet)
- Vol. 60 (2) , 101-108-108
Open AccessFormulación y evaluación de ketoprofeno cargado de nanogel de quitosán para el manejo del dolor: estudio ex vivo e in vivo
Objetivo: El objetivo de este estudio fue desarrollar y evaluar un gel a base de nanoemulsión (nanogel) para el suministro transdérmico de ketoprofeno. Entre los diversos excipientes probados, se seleccionaron el ácido oleico, la mezcla de 80 y el etanol como aceite, surfactante y co-surfactante. Métodos: La región de las nanoemulsiones se identificó mediante la construcción de diagramas de fase pseudoternarios utilizando la titulación de la fase acuosa. La nanoemulsión preparada se sometió a diferentes estudios de estabilidad termodinámica y la nanoemulsión que pasó las pruebas de estabilidad termodinámica se evaluó para determinar la viscosidad, el índice de refracción, el tamaño de las gotitas, la microscopía electrónica de transmisión y el estudio de permeación ex-vivo utilizando piel de cadáver humano Resultados: Sobre la base de la evaluación, la formulación de C1, que consiste en 3.09% peso / peso de la fase oleosa, 60.54% peso / peso de Smix y 36.36% peso / peso de agua destilada se seleccionaron como una formulación optimizada y se convirtieron a nanogel utilizando quitosano como Un agente gelificante. Nanogel se evaluó para estudio ex-vivo e in vivo. El nanogel mostró un aumento significativo en la actividad antiinflamatoria en comparación con el gel convencional. Conclusión: En conclusión, el nanogel podría ser un sistema prometedor para mejorar la administración transdérmica del ketoprofeno.
- 1 January 2019
- Published by Bentham Science Publishers Ltd. in Current Nanomedicine
- Vol. 8 (3) , 251-263
Terbinafine Hydrochloride Nanoemulsion Gel for Transdermal Delivery in Fungal Infection: Ex-vivo and In-vivo Evaluation
The present investigation was focused to formulate and optimized nanoemulsion of TFH and converting them as a suitable transdermal nanoemulsion gel (TNG) for to improve therapeutic efficacy, better dispersity, and storage stability in the treatment of fungal infection. The nanoemulsion was characterized for droplet size, polydispersity index (PDI), refractive index, drug content, viscosity, and morphology. The nanoemulsion formulation were incorporated into the gel for control release and evaluated for pH, drug content, and viscosity. Ex-vivo permeation study was conducted using human cadaver skin on nanoemulsion gel (TNG) and a marketed gel. The formulation A1 showed desired droplet size (133.0 ± 10.5 nm), PDI (0.174± 0.01), refractive index (1.334±0.05), drug content (99.12± 2.5 %) and viscosity (45.85± 4.60 cp). In ex-vivo permeation study, TNG showed significant (p0.05) were found in the values of pH, drug content and viscosity over the period of 3 months. In conclusion, TNG was found to have great potential to serve as a transdermal preparation, excellent antifungal activity, and safe with better storage stability.
- 1 January 2019
- Published by Bentham Science Publishers Ltd. in Current Nanomedicine
- Vol. 8 (3) , 251-263
Terbinafine Hydrochloride Nanoemulsion Gel for Transdermal Delivery in Fungal Infection: Ex-vivo and In-vivo Evaluation
The present investigation was focused to formulate and optimized nanoemulsion of TFH and converting them as a suitable transdermal nanoemulsion gel (TNG) for to improve therapeutic efficacy, better dispersity, and storage stability in the treatment of fungal infection. The nanoemulsion was characterized for droplet size, polydispersity index (PDI), refractive index, drug content, viscosity, and morphology. The nanoemulsion formulation were incorporated into the gel for control release and evaluated for pH, drug content, and viscosity. Ex-vivo permeation study was conducted using human cadaver skin on nanoemulsion gel (TNG) and a marketed gel. The formulation A1 showed desired droplet size (133.0 ± 10.5 nm), PDI (0.174± 0.01), refractive index (1.334±0.05), drug content (99.12± 2.5 %) and viscosity (45.85± 4.60 cp). In ex-vivo permeation study, TNG showed significant (p0.05) were found in the values of pH, drug content and viscosity over the period of 3 months. In conclusion, TNG was found to have great potential to serve as a transdermal preparation, excellent antifungal activity, and safe with better storage stability.
- 1 April 2018
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 44, 49-57
Curcumin loaded ethosomes for transdermal application: Formulation, optimization, in-vitro and in-vivo study
- 1 April 2018
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 44, 49-57
Curcumin loaded ethosomes for transdermal application: Formulation, optimization, in-vitro and in-vivo study
- 5 February 2018
- Published by Taylor & Francis in International Journal of Polymeric Materials and Polymeric Biomaterials
- Vol. 68 (4) , 165-174
Curcumin loaded fish scale collagen-HPMC nanogel for wound healing application:Ex-vivoandIn-vivoevaluation
The objective of the present investigation was to formulate curcumin loaded fish scale collagen (FSC)-hydroxypropyl methyl cellulose (HPMC K100) nanogel (CNG) for wound healing application. The curcumin nanoemulsion was prepared, characterized and loaded in FSC-HPMC nanogel. The nanogel was evaluated for ex-vivo permeation, in-vivo, skin irritation, and stability study. Ex-vivo permeation study demonstrated that CNG prolonged release and exhibited higher percent contraction value of wound compared to other formulations. In skin irritation study, formulation produced the score of less than 2 compared to control. It concluded that curcumin loaded FSC-HPMC nanogel could be prepared for wound healing applications.
- 5 February 2018
- Published by Taylor & Francis in International Journal of Polymeric Materials and Polymeric Biomaterials
- Vol. 68 (4) , 165-174
Curcumin loaded fish scale collagen-HPMC nanogel for wound healing application:Ex-vivoandIn-vivoevaluation
The objective of the present investigation was to formulate curcumin loaded fish scale collagen (FSC)-hydroxypropyl methyl cellulose (HPMC K100) nanogel (CNG) for wound healing application. The curcumin nanoemulsion was prepared, characterized and loaded in FSC-HPMC nanogel. The nanogel was evaluated for ex-vivo permeation, in-vivo, skin irritation, and stability study. Ex-vivo permeation study demonstrated that CNG prolonged release and exhibited higher percent contraction value of wound compared to other formulations. In skin irritation study, formulation produced the score of less than 2 compared to control. It concluded that curcumin loaded FSC-HPMC nanogel could be prepared for wound healing applications.
- 3 October 2017
- Published by Marmara University in Marmara Pharmaceutical Journal
- Vol. 21 (4) , 810-817
Analgesic and anti-inflammatory activity of crude leaf and bark extract of Lantana Camara
- 3 October 2017
- Published by Marmara University in Marmara Pharmaceutical Journal
- Vol. 21 (4) , 810-817
Analgesic and anti-inflammatory activity of crude leaf and bark extract of Lantana Camara